Antisaccades as a follow-up tool in major depressive disorder therapies: a pilot study.
Eight patients with major depression, included in a double-blind study, performed an antisaccade task. Results suggested a link between antisaccade performances and clinical scale scores in patients who respond to therapy. Moreover, error rates may well predict response from day of inclusion, thus serving as a state-marker for mood disorders.
Psychology and NeuroCognition Laboratory (LPNC, CNRS, UMR 5105), Grenoble, France. Jennifer.malsert@upmf-grenoble.fr
Jennifer
J
Malsert
Nathalie
N
Guyader
Alan
A
Chauvin
Mircea
M
Polosan
Emmanuel
E
Poulet
David
D
Szekely
Thierry
T
Bougerol
Christian
C
Marendaz
D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000503:physiopathology* / Q000628:therapy*; D061218:Depressive Disorder, Treatment-Resistant / Q000188:drug therapy* / Q000503:physiopathology*; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012438:Saccades / Q000502:physiology*; D016896:Treatment Outcome
D000928:Antidepressive Agents